Vanguard Portfolio Management
VYGR icon

Vanguard Portfolio Management’s Voyager Therapeutics VYGR Stock Holding History

Vanguard Portfolio Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.84M Buy
810,091
+84,322
+12% +$320K ﹤0.01% 2626
2026
Q1 		$2.8M Buy
+725,769
New +$2.86M ﹤0.01% 2503

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Vanguard Portfolio Management's VYGR Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Voyager Therapeutics (VYGR) stake by 12% in Q2 2026, buying an estimated $320K and bringing the position to 810,091 shares worth $2.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2626.

Vanguard Portfolio Management first reported a position in VYGR in Q1 2026 and has held it in 2 quarters since. 128 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Vanguard Portfolio Management held 810,091 shares of Voyager Therapeutics worth $2.84M as of Q2 2026.
  • Vanguard Portfolio Management bought 84,322 Voyager Therapeutics shares in Q2 2026, an estimated $320K.
  • Voyager Therapeutics made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2626 holding.
  • Vanguard Portfolio Management first reported a position in Voyager Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 128 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.